Articles On Telix Pharmaceuticals (ASX:TLX)

Sometimes the best opportunities come when the market is looking the other way. Right now, a handful of promising ASX shares are trading well below their recent highs or flying under the radar altogether. For investors willing to act early,...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Sept. 23, 2025 /PRNewswire/ – IMRA Surgical, an Australian-...

Highlights Key ASX-listed companies marked fresh yearly highs and lows across diverse sectors. Gold miners, REITs, and financial firms dominated the high ranks. Healthcare and discretionary sectors showed weakness with multi...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

It was an upbeat end to the trading week this Friday, with the S&P/ASX 200 Index (ASX: XJO) bouncing back to close 0.32% higher. After a few days of negative sentiment, investors evidently decided to...

ASX pares back early gains to lift 0.32pc Healthcare, tech, utilities drive gains Resources sector drags as gold prices slip from highs ASX gets clean bill of health The ASX was looking a little healthier today, adding 0.32% or 28.3 poi...

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, host Tylah Tully looks into the share price increase of big gun radiopharmaceuticals company Telix Pharmaceuticals (ASX:TLX), which surge...

ASX heath sector fell 0.37% over past five days, while broader markets down 0.5% Telix finds way forward with the FDA on brain cancer imaging agent Pixclara Big Pharma to showcase Clever Culture Systems tech at major global conferences  ...

Highlights Healthcare Sector Faces Challenges: Companies like (ASX:CSL) are experiencing significant declines. Gold Stocks Show Resilience: (ASX:RSG), (ASX:EVN), and (ASX:RRL) demonstrate notable gains. Short Selling Activities o...

Pitt Street Research says Imagion is significantly undervalued and sits around 75-80% below target range of 12.3 to 14.9 cents per share Research house sees further upside if MagSense imaging agent tech progresses to commercialisation in a...

If you have $10,000 to invest in the ASX today, but don't know which stocks to choose, take a look at my two top picks for the week. NextDC Ltd (ASX: NXT) Outperformance of shares in the technology sector this week has helped to offs...

It was a day of relief for investors this Wednesday, as the S&P/ASX 200 Index (ASX: XJO) shook off the malaise that afflicted the markets earlier this week to push higher.  By the time trading wrapp...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up 0.25% to 8,827.1 points. Four ASX shares that are rising more than most today are listed below....

History tells us that September can be a turbulent month for ASX 200 shares as the dust settles on earnings season results. On trend, the S&P/ASX 200 Index (ASX: XJO) has shed 1.4% already this month.  However, this can also be an...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, Sept. 10, 2025 /PRNewswire/ — Telix Pharma...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin US markets moved higher, tickling near all time high levels despite a downward revis...

Highlights Artrya (ASX:AYA) expands with major funding for heart disease detection devices Telix Pharmaceuticals (ASX:TLX) advances brain cancer imaging with FDA alignment Argenica Therapeutics (ASX:AGN) gains traction with...

Highlights Short interest themes reshape focus across banks, miners, retail, and healthcare Coverage trends diverge as catalysts hit balance sheets and project pipelines Market tone split between cyclical caution and themati...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is racing higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed yesterday trading for $13.60. In earlier trade shares were up mo...

Highlights Short-selling trends mapped to miners, banks, retail, healthcare, tech, and real estate Brief, entity-rich snapshots for each company referenced with one clean ticker mention Neutral tone focused on activity, sect...

Highlights Short sellers increase activity across multiple S&P/ASX 200 companies, spanning travel, food, healthcare, and resources. Companies such as Flight Centre (ASX:FLT), Domino’s Pizza (ASX:DMP), and Guzman y Gomez (ASX:...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Despite at times a bruising August reporting season, the index topped new all time h...

The FDA has requested more data from a slew of ASX drug developers requesting marketing approval, or permission to undertake a trial Telix has received two FDA ‘complete response’ letters, but the company says investors should not be conce...

With earnings season over, investors may be reflecting on last month's results and significant share price moves. This exercise can provide insight into which companies and sectors have momentum behind them. It can also identify compani...

Highlights Companies like Telix (ASX:TLX), Austal (ASX:ASB), Pro Medicus (ASX:PME), and Cochlear (ASX:COH) continue to strengthen their US footprint. CSL (ASX:CSL), Reece (ASX:REH), Unibail-Rodamco-Westfield (ASX:URW), and Guzman...

Highlights IPH and Monash IVF Group experience sharp increases in short interest following earnings updates Reliance Worldwide and Inghams see rising shorts amid weaker performance and outlooks Clinuvel and Novonix lead the...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Weekly update on stockbroker recommendation, target price, and earnings forecast cha...

If you are hunting for big returns for your investment portfolio, then look no further than the ASX 200 shares in this article. That's because analysts are tipping them to rise by 25%+ over the next 12 months. Here's what you need to know a...

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these...

The government has just handed first home buyers what looks like a golden ticket, but it could be the fuse for a ticking time bomb. Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from t...

ASX rises 0.22pc after flat day of trade Earnings reports from big cap companies weighed heavy Gains and losses equalised after lunch for steady end to day ASX edges higher on earnings equilibrium It was another tale of heroes and villai...

The ASX200 traded flat today leading into close. Real Estate was the best performing sector, followed by Financials and Industrials. Energy was by far the worst performing sector, followed by Health Care and IT. In the Green Qa...

In late trade on Thursday, the S&P/ASX 200 Index (ASX: XJO) is on track to record a small gain. At the time of writing, the benchmark index is up 0.1% to 8,972.1 points. Four ASX shares that have failed to follow the market higher today...

Highlights Australian shares hovered near flat as gains in financials offset losses in healthcare Qantas and IDP Education stood out with strong market interest amid corporate updates Telix Pharmaceuticals and Ramsay Health...

With more than seven million users on the HotCopper forums, every discussion and speculation can move Australian markets – which is why getting out in front of those trends is so important for any trader worth their salt. Listen to the H...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are getting pounded today. Shares in the S&P/ASX 200 Index (ASX: XJO) diagnostic and therapeutic product developer closed yesterday trading for $18.40. In earlier trade, shares crashed to $13....

The FDA has refused Telix’s kidney imaging marketing application, sending shares into a $1.1 billion plus tailspin With Somnomed firing, investors (and patients) are sleeping easier Alcidion is back in black on UK hospital demand   Radiop...

Telix (ASX:TLX) has experienced a jolt in its recovery following its July 22 quarterly that saw prices sink – now, the FDA has knocked back an investigational PET scan agent Telix submitted, lengthening out that product’s path to sales. Per...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin FNArena's Monitor keeps track of corporate earnings result releases, including broke...

  Highlights ASX 200 and All Ordinaries surged to new highs with strength across all sectors Industrials, Consumer Staples, and Consumer Discretionary led gains with strong moves from key stocks Battery metals and rare eart...

It has been another busy week for many of Australia's top brokers. This has led to the release of a number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these...

Telix Pharmaceuticals Ltd (ASX: TLX) shares were on form on Thursday. The ASX 200 biotech stock raced 7% higher to end the session at $18.10. This was driven by the release of its half year results for FY 2025. Where next for Telix shares?...

ASX smashes records to close at intraday high of 9019 points Market shows impressive strength, with every sector and index moving higher Industrials sector a powerhouse of momentum   It’s over 9000!! The ASX is well and truly showing its...

It was a watershed day for the S&P/ASX 200 Index (ASX: XJO) this Thursday. Today marked the first time in history that the ASX 200 ascended past the 9,000-point mark, once again resetting its record...

The ASX 200 has smashed through the big 9,000 mark for the first time ever, hitting a fresh all-time high of 9,013 in intraday trade. Yep, we’ve finally cracked it! Industrials led the charge in sectors, giving the market a solid boost,...

  Highlights Objective Corporation (ASX:OCL), Super Retail Group (ASX:SUL), and Codan (ASX:CDA) led early gains on the index Brambles (ASX:BXB) advanced with strong results and capital return updates Megaport (ASX:MP1) and...

  Highlights Banks including (ASX:ANZ), (ASX:NAB) and (ASX:WBC) remained firm within the asx 200 Real estate majors such as (ASX:CHC), (ASX:SCG) and (ASX:SGP) advanced across sessions Uptrend and downtrend scans reflected c...

Highlights US markets ease ahead of Jackson Hole meeting Defensive sectors support local benchmark Busy earnings calendar for ASX companies The ASX 200 stocks are expected to open on a positive note as global cues continue to shap...

  Highlights Evolution Mining (ASX:EVN) noted for exposure to both gold and copper markets Telix Pharmaceuticals (ASX:TLX) recognised for advancements in radiopharmaceutical development Both companies are listed on the ASX...